1-4 of 4
Gabriel Marquez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASC4REAL: Efficacy and Tolerability Comparison between Ascembl Study, a Phase 3 Randomized Clinical Trial (RCT), and Consolidated Real-World (RW) Evidence with Asciminib in CML Patients Beyond 2 TKIs

Anchit Khanna, Hannah Small, Dhamend Lutchman, Rafael Erlich, Gabriel Marquez, Daisy Yang, Kejal Jadhav
Journal: Blood
Blood (2024) 144 (Supplement 1): 4527.
https://doi.org/10.1182/blood-2024-201022
Published: 2024
Journal Articles

A Phase I Trial of CC-486, Lenalidomide, Obinutuzumab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Gabriel Marquez-Arreguin, Tamer Othman, Naseem S. Esteghamat, Mehrdad Abedi, Francisco Andres Socola, Joseph M Tuscano
Journal: Blood
Blood (2024) 144 (Supplement 1): 6317.
https://doi.org/10.1182/blood-2024-209452
Published: 2024
Journal Articles

Gut-associated lymphoid tissue–primed CD4 + T cells display CCR9-dependent and -independent homing to the small intestine

Hanna Stenstad, Anna Ericsson, Bengt Johansson-Lindbom, Marcus Svensson, Jan Marsal, Matthias Mack, Dominic Picarella, Dulce Soler, Gabriel Marquez, Mike Briskin, William W. Agace
Journal: Blood
Blood (2006) 107 (9): 3447–3454.
https://doi.org/10.1182/blood-2005-07-2860
Published: 2006
Journal Articles

CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress

Brief Report
Anja Meissner, Olaf Zilles, Rosa Varona, Katrin Jozefowski, Uwe Ritter, Gabriel Marquez, Rupert Hallmann, Heinrich Körner
Journal: Blood
Blood (2003) 102 (8): 2724–2727.
https://doi.org/10.1182/blood-2003-01-0007
Published: 2003